Why are you looking at Adc Therapeutics America?
Email me when a Adc Therapeutics America recompete window opens.
Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
Sole agencyMostly sole-source · 100%
100% of Adc Therapeutics America’s obligations are not openly competed — these contracts typically renew with the incumbent rather than going to recompete.
Agency buyer map
1 buyersRecompete exposure
LowLargely sole-source — these contracts typically renew with Adc Therapeutics America rather than being openly recompeted.
Adc Therapeutics America has an estimated $194K in contracts returning to market over the next 24 months.
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Adc Therapeutics America hold?
Adc Therapeutics America (UEI Y9MBZX2C5RU5) shows $194K across 2 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Adc Therapeutics America have?
Adc Therapeutics America shows $194K across 2 award actions. SCOUT tracks 1 incumbent recompetes ($194K) returning to market in the next 24 months.
Which agencies does Adc Therapeutics America work with?
Adc Therapeutics America’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).
What is the UEI for Adc Therapeutics America?
The Unique Entity ID (UEI) for Adc Therapeutics America is Y9MBZX2C5RU5.
Does Adc Therapeutics America have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Adc Therapeutics America — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.